Search Results - "Cheneau, Caroline"

Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial by Baciarello, Giulia, Delva, Remy, Gravis, Gwenaelle, Tazi, Youssef, Beuzeboc, Philippe, Gross-Goupil, Marine, Bompas, Emmanuelle, Joly, Florence, Greilsamer, Charlotte, Hon, Thierry Nguyen Tan, Barthelemy, Philippe, Culine, Stephane, Berdah, Jean Francois, Deblock, Mathilde, Ratta, Raffaele, Flechon, Aude, Cheneau, Caroline, Maillard, Aline, Martineau, Geraldine, Borget, Isabelle, Fizazi, Karim

“…Recent data suggest that cabazitaxel and docetaxel have similar activity but a different safety profile in the first-line metastatic castration-resistant…”
Get full text

Predictive and prognostic factors for gliomas by Ducray, François, Idbaih, Ahmed, Wang, Xiao-Wei, Cheneau, Caroline, Labussiere, Marianne, Sanson, Marc

“…Despite recent therapeutic advances, gliomas, in particular the most frequent and malignant glioblastoma, remain devastating tumors and need a better molecular…”
Get full text

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19) by Turpin, Anthony, Thariat, Juliette, Debieuvre, Didier, Wislez, Marie, Mansi, Laura, Colomba, Emeline, Idbaih, Ahmed, Zalcman, Gérard, Aparicio, Thomas, Goasdoue, Henri, Khamari, Marwa, Regimbeau, Jean Marc, Hautefeuille, Vincent, Dehais, Mélanie, Talfi, Safia, Benrezzak, Nasro, Vignes, Emanuelle, Hocine, Fayçal, Almotlak, Hamadi, Sun, Xu-Shan, Wasselin, Julie, Fadin, Aurélie, Ramdani, Mohamed, Garbay, Delphine, Trouba, Cécile, Babin, Emmanuel, Leon, Vincent, Desauw, Christophe, Peres, Christina, Mille, Dominique, Combe, Pierre, Jonveaux, Eric, Kaluzinski, Laure, Riviere, Frédéric, Moreau, Lionel, Ahle, Guido, Degriffolet, Dominique, Sebbagh, Virginie, Lozach-Brugirard, Marion, Loutski, Sandrine, Cattelain, Sophie, Darloy, Franck, Jolimoy Boilleau, Geneviève, Maissiat, Cyrielle, Charifi-Alaoui, Ikram, Valenza, Bruno, Paitel, Jean-François, Kreitmann, Thomas, Boucheret, Paul, Tchikladze, Christine, Herve, Camille, Bieber, Elsa, Rosso, Maud, Pham-Becker, Alice, Louafi, Samy, Egreteau, Joëlle, Prunier-Bossion, Florence, Ray Coquard, Isabelle, Norguet Monnereau, Emmanuelle, Boucard, Céline, Locher, Christophe, Auby, Dominique, Petran, Daniela, Rousseau, Dominique, Castanie, Hélène, Vannetzel, Jean-Michel, Roger, Antoine, Stroksztejn, Magda, Aparicio, Thomas, Simon Anne, Sophie, Wislez, Marie, Vo, Maryline, Brouk, Zohra, Colle, Raphaël, Bennamoun, Mostefa, Idbaih, Ahmed, Raymond, Eric, Palmieri, Lola Jade, Goujon, Gaël, Gazeau, Benoit, Belkhir, Kahina, Spano, Jean-Philippe, Gibiat, Stéphanie, Suc, Etienne, Dewolf, Maxime, Dumazet, Antoine, Marchand-Crety, Charles, Fosse, Patricia, Ferrand, François-Régis, Ligeza Poisson, Catherine, Williet, Nicolas, Ramirez, Carole, Perruisseau-Carrier, Joffrey, Barret, Flavie, Barlet, Agnès, Vernisse, Mylène, Lafond, Sophie, Panouille, Quentin, Cambula, Linda, GermaIn, Adeline

“…Cancer patients are thought to have an increased risk of developing severe Coronavirus Disease 2019 (COVID-19) infection and of dying from the disease. In this…”
Get full text

Efficacy of AI and palbociclib in ER+ HER2- advanced breast cancer patients relapsing during adjuvant tamoxifen: An exploratory analysis of the PADA-1 trial by Bidard, François-Clément, Dalenc, Florence, De La Motte Rouge, Thibault, Pistilli, Barbara, Cheneau, Caroline, Delbaldo, Catherine, Derbel, Olfa, Garnier Tixidre, Claire, Marques, Nathalie, Marques, Sandrine, Moreau, Lionel, Berger, Frederique, Lemonnier, J, Hardy-Bessard, Anne-Claire, Delaloge, Suzette, Bachelot, Thomas

“…Abstract only 1070 Background: In PADA-1 (NCT03079011), a phase III trial testing the clinical utility of ESR1 mut detection, ER+ HER2- advanced breast…”
Get full text

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY by Balmaña, Judith, Fasching, Peter A., Couch, Fergus J., Delaloge, Suzette, Labidi-Galy, Intidhar, O’Shaughnessy, Joyce, Park, Yeon Hee, Eisen, Andrea F., You, Benoit, Bourgeois, Hughes, Gonçalves, Anthony, Kemp, Zoe, Swampillai, Angela, Jankowski, Tomasz, Sohn, Joo Hyuk, Poddubskaya, Elena, Mukhametshina, Guzel, Aksoy, Sercan, Timcheva, Constanta V., Park-Simon, Tjoung-Won, Antón-Torres, Antonio, John, Ellie, Baria, Katherine, Gibson, Isabel, Gelmon, Karen A.

“…Purpose The interim analysis of the phase IIIb LUCY trial demonstrated the clinical effectiveness of olaparib in patients with germline BRCA-mutated (gBRCAm),…”
Get full text

Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent Glioblastoma by Labussière, Marianne, Cheneau, Caroline, Prahst, Claudia, Gállego Pérez-Larraya, Jaime, Farina, Patrizia, Lombardi, Giuseppe, Mokhtari, Karima, Rahimian, Amithys, Delattre, Jean-Yves, Eichmann, Anne, Sanson, Marc

“…Despite encouraging response rate of bevacizumab (BVZ) in recurrent glioblastoma, many patients do not respond to this schedule and most of the responders…”
Get full text

Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients by Voog, Eric, Campillo‐Gimenez, Boris, Elkouri, Claude, Priou, Franck, Rolland, Frederic, Laguerre, Brigitte, Elhannani, Chaza, Merrer, Jacques, Pfister, Christian, Sevin, Emmanuel, L'Haridon, Tifenn, Hasbini, Ali, Moise, Laura, Le Rol, Annick, Malhaire, Jean Pierre, Delva, Remy, Vauléon, Elodie, Cojocarasu, Oana, Deguiral, Philippe, Cumin, Isabelle, Cheneau, Caroline, Schlürmann, Friedrike, Delecroix, Valérie, Boughalem, Elouen, Mollon, Delphine, Ligeza‐Poisson, Catherine, Abadie‐Lacourtoisie, Sophie, Monpetit, Erik, Chatellier, Thierry, Desclos, Henry, Coquan, Elodie, Joly, Florence, Tessereau, Jean Yves, Dupuy, Sandra, Déniel Lagadec, Delphine, Marhuenda, Fanny, Grudé, Francoise

“…The treatment landscape in metastatic renal cell carcinoma has changed fundamentally over the last decade by the development of antiangiogenic agents,…”
Get full text

Trastuzumab induced cardiotoxicity in HER2-positive metastatic esogastric cancers by Martin-Babau, Jerome, Eusen, Yves, Verveur, Cedric, Trouboul, Fanny, Cheneau, Caroline, Jestin Le Tallec, Veronique, Simon, Helene, Metges, Jean-Philippe

“…Abstract only 152 Background: Trastuzumab is widely used in Her2 positive metastatic esophageal and gastric cancers along with chemotherapy. Cardiotoxicity of…”
Get full text

Final results from the randomized CABADOC trial: Patient preference between cabazitaxel and docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC) by Baciarello, Giulia, Delva, Remy, Gravis, Gwenaelle, Tazi, Youssef, Theodore, Christine, Gross-Goupil, Marine, Bompas, Emmanuelle, Joly, Florence, Lharidon, Tifenn, Nguyen Tan Hon, Thierry, Barthelemy, Philippe, Culine, Stephane, Berdah, Jean Francois, Deblock, Mathilde, Beuzeboc, Philippe, Flechon, Aude, Cheneau, Caroline, Martineau, Geraldine, Borget, Isabelle, Fizazi, Karim

“…Abstract only 5017 Background: Docetaxel and cabazitaxel represent now the standard of care in men with mCRPC with similar efficacy reported in metastatic…”
Get full text

VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab by Di Stefano, Anna Luisa, Labussiere, Marianne, Lombardi, Giuseppe, Eoli, Marica, Bianchessi, Donata, Pasqualetti, Francesco, Farina, Patrizia, Cuzzubbo, Stefania, Gallego-Perez-Larraya, Jaime, Boisselier, Blandine, Ducray, Francois, Cheneau, Caroline, Moglia, Arrigo, Finocchiaro, Gaetano, Marie, Yannick, Rahimian, Amithys, Hoang-Xuan, Khe, Delattre, Jean Yves, Mokhtari, Karima, Sanson, Marc

“…Although anti-VEGF therapy is widely used in high-grade gliomas, no predictor of response or toxicity has been reported yet. We investigated here the…”
Get full text

Predictive factors of bevacizumab efficacy in relapsed glioblastoma patients by Farina, Patrizia, Labussiere, Marianne, Lombardi, Giuseppe, Di Stefano, Anna Luisa, Gallego, Jaime, Cheneau, Caroline, Zagonel, Vittorina, Sanson, Marc

“…Abstract only…”
Get full text

Association of VEGFA SNP rs2010963 with prognosis and prediction of vascular toxicity of bevacizumab in recurrent glioblastomas by Di Stefano, Anna Luisa, Lombardi, Giuseppe, Gallego Perez-Larraya, Jaime, Boisselier, Blandine, Labussiere, Marianne, Ducray, Francois, Zagonel, Vittorina, Cheneau, Caroline, Delattre, Jean-Yves, Sanson, Marc

“…Abstract only 2028 Background: VEGFA has become an attractive target in high grade gliomas but there is no predictor of response or toxicity to anti-VEGF…”
Get full text